These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 38308461)

  • 1. Genetic and non-genetic drug resistance: Darwin or Lamarck?
    Russo M
    Mol Oncol; 2024 Feb; 18(2):241-244. PubMed ID: 38308461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the role of phenotypic switching in cancer drug resistance.
    Gunnarsson EB; De S; Leder K; Foo J
    J Theor Biol; 2020 Apr; 490():110162. PubMed ID: 31953135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long Non-coding RNAs and Drug Resistance.
    Pan JJ; Xie XJ; Li X; Chen W
    Asian Pac J Cancer Prev; 2015; 16(18):8067-73. PubMed ID: 26745040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Genetic/Non-genetic Duality of Drug 'Resistance' in Cancer.
    Salgia R; Kulkarni P
    Trends Cancer; 2018 Feb; 4(2):110-118. PubMed ID: 29458961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of anti-tumour drug resistance with epigenetic regulation.
    Hayashi T; Konishi I
    Br J Cancer; 2021 Feb; 124(4):681-682. PubMed ID: 33268818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance.
    Easwaran H; Tsai HC; Baylin SB
    Mol Cell; 2014 Jun; 54(5):716-27. PubMed ID: 24905005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic enzyme mutations as mediators of anti-cancer drug resistance.
    Chen S; Zhao Y; Liu S; Zhang J; Assaraf YG; Cui W; Wang L
    Drug Resist Updat; 2022 Mar; 61():100821. PubMed ID: 35219075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-genetic mechanisms of therapeutic resistance in cancer.
    Marine JC; Dawson SJ; Dawson MA
    Nat Rev Cancer; 2020 Dec; 20(12):743-756. PubMed ID: 33033407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting epigenetic regulatory machinery to overcome cancer therapy resistance.
    Guo L; Lee YT; Zhou Y; Huang Y
    Semin Cancer Biol; 2022 Aug; 83():487-502. PubMed ID: 33421619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance.
    Wilting RH; Dannenberg JH
    Drug Resist Updat; 2012; 15(1-2):21-38. PubMed ID: 22356866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The multi-factorial nature of clinical multidrug resistance in cancer.
    Assaraf YG; Brozovic A; Gonçalves AC; Jurkovicova D; Linē A; Machuqueiro M; Saponara S; Sarmento-Ribeiro AB; Xavier CPR; Vasconcelos MH
    Drug Resist Updat; 2019 Sep; 46():100645. PubMed ID: 31585396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor microenvironment-driven non-cell-autonomous resistance to antineoplastic treatment.
    Qu Y; Dou B; Tan H; Feng Y; Wang N; Wang D
    Mol Cancer; 2019 Mar; 18(1):69. PubMed ID: 30927928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The bitter side of epigenetics: variability and resistance to chemotherapy.
    Hajji N; García-Domínguez DJ; Hontecillas-Prieto L; O'Neill K; de Álava E; Syed N
    Epigenomics; 2021 Mar; 13(5):397-403. PubMed ID: 29932342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of resistance to targeted anti-cancer therapies during continuous and pulsed administration strategies.
    Foo J; Michor F
    PLoS Comput Biol; 2009 Nov; 5(11):e1000557. PubMed ID: 19893626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrating mutational and nonmutational mechanisms of acquired therapy resistance within the Darwinian paradigm.
    Vander Velde R; Shaffer S; Marusyk A
    Trends Cancer; 2022 Jun; 8(6):456-466. PubMed ID: 35307314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the specific epigenetic alterations associated with chemo-resistance via reprogramming of cancer cells.
    Kim JJ; Rai R
    Med Hypotheses; 2015 Dec; 85(6):710-4. PubMed ID: 26527497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and Epigenetic Modulation of Drug Resistance in Cancer: Challenges and Opportunities.
    Shah K; Rawal RM
    Curr Drug Metab; 2019; 20(14):1114-1131. PubMed ID: 31902353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surmounting cancer drug resistance: New insights from the perspective of N
    Li B; Jiang J; Assaraf YG; Xiao H; Chen ZS; Huang C
    Drug Resist Updat; 2020 Dec; 53():100720. PubMed ID: 32892147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug resistance in colorectal cancer: An epigenetic overview.
    Luo M; Yang X; Chen HN; Nice EC; Huang C
    Biochim Biophys Acta Rev Cancer; 2021 Dec; 1876(2):188623. PubMed ID: 34481016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetics and metabolism at the crossroads of stress-induced plasticity, stemness and therapeutic resistance in cancer.
    Ravindran Menon D; Hammerlindl H; Torrano J; Schaider H; Fujita M
    Theranostics; 2020; 10(14):6261-6277. PubMed ID: 32483452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.